Protease-activated receptors: development of agonists selective for receptors triggered by either thrombin (PAR1) or trypsin (PAR2).
Kawabata
A
A
Department of Pharmacology, University of Calgary, Faculty of Medicine, Canada.
Saifeddine
M
M
al-Ani
B
B
Hollenberg
M D
MD
D000818:Animals; D002118:Calcium / Q000378:metabolism; D002460:Cell Line; D006801:Humans; D009842:Oligopeptides / Q000494:pharmacology; D010446:Peptide Fragments / Q000494:pharmacology; D044463:Receptor, PAR-1; D044464:Receptor, PAR-2; D011956:Receptors, Cell Surface / Q000819:agonists*; D018179:Receptors, Thrombin / Q000819:agonists*; D013917:Thrombin / Q000378:metabolism*; D014357:Trypsin / Q000378:metabolism*; D014981:Xenopus
D009842:Oligopeptides; D010446:Peptide Fragments; D044463:Receptor, PAR-1; D044464:Receptor, PAR-2; D011956:Receptors, Cell Surface; D018179:Receptors, Thrombin; D014357:Trypsin; D013917:Thrombin; D002118:Calcium